Etiopathogenesis of alopecia areata: Why do our patients get it?

Dermatologic Therapy

Volumn 24, Issue 3, 2011, Pages 337-347

  Wang, Eddy ^a   McElwee, Kevin J ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER COASTAL HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

alopecia areata; autoimmune disease; disease pathogenesis

Indexed keywords

AUTOANTIBODY; HEPATITIS B VACCINE; IMMUNOGLOBULIN G; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SOYBEAN OIL;

ALOPECIA AREATA; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ARTICLE; ATOPY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELLULAR IMMUNITY; CYTOMEGALOVIRUS INFECTION; DIET THERAPY; DISEASE DURATION; DISEASE MODEL; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; FOOD INTAKE; GENETIC ASSOCIATION; HAIR FOLLICLE; HAIR GROWTH; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATORY CELL; LYMPHOCYTIC INFILTRATION; MENTAL STRESS; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; RISK REDUCTION; VACCINATION;

ALOPECIA AREATA; ANIMALS; AUTOIMMUNITY; HUMANS; SEVERITY OF ILLNESS INDEX;

EID: 79959558066     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2011.01416.x     Document Type: Article

References (127)

1. Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J,. Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol 2010: 62: 177-188. quiz 189-190.
2. Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J,. Alopecia areata update: part II. Treatment. J Am Acad Dermatol 2010: 62: 191-202. quiz 203-194.
3. Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ 3rd,. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc 1995: 70: 628-633.
4. Kos L, Conlon J,. An update on alopecia areata. Curr Opin Pediatr 2009: 21: 475-480.
5. McMichael AJ, Pearce DJ, Wasserman D, et al,. Alopecia in the United States: outpatient utilization and common prescribing patterns. J Am Acad Dermatol 2007: 57: S49-S51. (Pubitemid 47048445)
6. Wasserman D, Guzman-Sanchez DA, Scott K, McMichael A,. Alopecia areata. Int J Dermatol 2007: 46: 121-131. (Pubitemid 46679412)
7. Gilhar A, Kalish RS,. Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Autoimmun Rev 2006: 5: 64-69. (Pubitemid 41759444)
8. Thomas EA, Kadyan RS,. Alopecia areata and autoimmunity: a clinical study. Indian J Dermatol 2008: 53: 70-74.
9. Shapiro J,. Clinical practice. Hair loss in women. N Engl J Med 2007: 357: 1620-1630. (Pubitemid 47598404)
10. Lu W, Shapiro J, Yu M, et al,. Alopecia areata: pathogenesis and potential for therapy. Expert Rev Mol Med 2006: 8: 1-19. (Pubitemid 43923144)
11. McElwee KJ, Sinclair R,. Hair physiology and its disorders. Drug Discov Today Dis Mech 2008: 5: e163-e171.
12. Zhang JG, Oliver RF,. Immunohistological study of the development of the cellular infiltrate in the pelage follicles of the DEBR model for alopecia areata. Br J Dermatol 1994: 130: 405-414. (Pubitemid 24204657)
13. Elston DM, McCollough ML, Bergfeld WF, Liranzo MO, Heibel M,. Eosinophils in fibrous tracts and near hair bulbs: a helpful diagnostic feature of alopecia areata. J Am Acad Dermatol 1997: 37: 101-106. (Pubitemid 27287701)
14. El Darouti M, Marzouk SA, Sharawi E,. Eosinophils in fibrous tracts and near hair bulbs: a helpful diagnostic feature of alopecia areata. J Am Acad Dermatol 2000: 42: 305-307. (Pubitemid 30469640)
15. Spath U, Steigleder GK,. Number of mast cells (MC) in Alopecia areata. Z Haut Geschlechtskr 1970: 45: 435-436.
16. Todes-Taylor N, Turner R, Wood GS, Stratte PT, Morhenn VB,. T cell subpopulations in alopecia areata. J Am Acad Dermatol 1984: 11: 216-223. (Pubitemid 14096790)
17. Freyschmidt-Paul PMK, Hoffmann R,. Alopecia areata. In:, Whiting DAB-PU, Tosti A, Trueb R, eds. Hair growth and disorders. Berlin: Springer, 2008: 311-320.
18. Whiting DA,. Histopathologic features of alopecia areata: a new look. Arch Dermatol 2003: 139: 1555-1559. (Pubitemid 37523073)
19. Ueno H, Klechevsky E, Morita R, et al,. Dendritic cell subsets in health and disease. Immunol Rev 2007: 219: 118-142. (Pubitemid 47393528)
20. Albert ML, Sauter B, Bhardwaj N,. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998: 392: 86-89. (Pubitemid 28150594)
21. Mehling A, Beissert S,. Dendritic cells under investigation in autoimmune disease. Crit Rev Biochem Mol Biol 2003: 38: 1-21. (Pubitemid 36308349)
22. Freyschmidt-Paul P, Seiter S, Zoller M, et al,. Treatment with an anti-CD44v10-specific antibody inhibits the onset of alopecia areata in C3H/HeJ mice. J Invest Dermatol 2000: 115: 653-657.
23. Zoller M, Freyschmidt-Paul P, Vitacolonna M, McElwee KJ, Hummel S, Hoffmann R,. Chronic delayed-type hypersensitivity reaction as a means to treat alopecia areata. Clin Exp Immunol 2004: 135: 398-408. (Pubitemid 38304893)
24. Gupta P, Freyschmidt-Paul P, Vitacolonna M, et al,. A chronic contact eczema impedes migration of antigen-presenting cells in alopecia areata. J Invest Dermatol 2006: 126: 1559-1573.
25. Zoller M, Gupta P, Marhaba R, Vitacolonna M, Freyschmidt-Paul P,. Anti-CD44-mediated blockade of leukocyte migration in skin-associated immune diseases. J Leukoc Biol 2007: 82: 57-71. (Pubitemid 47026416)
26. McElwee KJ, Tobin DJ, Bystryn JC, King LE Jr, Sundberg JP,. Alopecia areata: an autoimmune disease? Exp Dermatol 1999: 8: 371-379. (Pubitemid 29487972)
27. McElwee KJ, Boggess D, King LE Jr, Sundberg JP,. Experimental induction of alopecia areata-like hair loss in C3H/HeJ mice using full-thickness skin grafts. J Invest Dermatol 1998: 111: 797-803. (Pubitemid 28509321)
28. McElwee KJ, Spiers EM, Oliver RF,. Partial restoration of hair growth in the DEBR model for alopecia areata after in vivo depletion of CD4+ T cells. Br J Dermatol 1999: 140: 432-437. (Pubitemid 29182873)
29. McElwee KJ, Spiers EM, Oliver RF,. In vivo depletion of CD8+ T cells restores hair growth in the DEBR model for alopecia areata. Br J Dermatol 1996: 135: 211-217. (Pubitemid 26252968)
30. Gilhar A, Landau M, Assy B, Shalaginov R, Serafimovich S, Kalish RS,. Mediation of alopecia areata by cooperation between CD4+ and CD8+ T lymphocytes: transfer to human scalp explants on Prkdc(SCID) mice. Arch Dermatol 2002: 138: 916-922. (Pubitemid 34700738)
31. McElwee KJ, Freyschmidt-Paul P, Hoffmann R, et al,. Transfer of CD8(+) cells induces localized hair loss whereas CD4(+)/CD25(-) cells promote systemic alopecia areata and CD4(+)/CD25(+) cells blockade disease onset in the C3H/HeJ mouse model. J Invest Dermatol 2005: 124: 947-957. (Pubitemid 40629095)
32. Carroll JM, McElwee KJ, E King L, Byrne MC, Sundberg JP,. Gene array profiling and immunomodulation studies define a cell-mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans. J Invest Dermatol 2002: 119: 392-402. (Pubitemid 35001949)
33. Bystryn JC, Orentreich N, Stengel F,. Direct immunofluorescence studies in alopecia areata and male pattern alopecia. J Invest Dermatol 1979: 73: 317-320. (Pubitemid 10165032)
34. Bernot KM, Coulombe PA, McGowan KM,. Keratin 16 expression defines a subset of epithelial cells during skin morphogenesis and the hair cycle. J Invest Dermatol 2002: 119: 1137-1149. (Pubitemid 35430491)
35. Steinert PM, Parry DA, Marekov LN,. Trichohyalin mechanically strengthens the hair follicle: multiple cross-bridging roles in the inner root shealth. J Biol Chem 2003: 278: 41409-41419. (Pubitemid 37280970)
36. Leung MC, Sutton CW, Fenton DA, Tobin DJ,. Trichohyalin is a potential major autoantigen in human alopecia areata. J Proteome Res 2010: 9: 5153-5163.
37. McElwee KJ, Pickett P, Oliver RF,. The DEBR rat, alopecia areata and autoantibodies to the hair follicle. Br J Dermatol 1996: 134: 55-63. (Pubitemid 26029664)
38. Tobin DJ, Sundberg JP, King LE Jr, Boggess D, Bystryn JC,. Autoantibodies to hair follicles in C3H/HeJ mice with alopecia areata-like hair loss. J Invest Dermatol 1997: 109: 329-333. (Pubitemid 27394647)
39. Tobin DJ, Hann SK, Song MS, Bystryn JC,. Hair follicle structures targeted by antibodies in patients with alopecia areata. Arch Dermatol 1997: 133: 57-61. (Pubitemid 27044306)
40. Tobin DJ,. Characterization of hair follicle antigens targeted by the anti-hair follicle immune response. J Investig Dermatol Symp Proc 2003: 8: 176-181. (Pubitemid 37222826)
41. Gilhar A, Pillar T, Assay B, David M,. Failure of passive transfer of serum from patients with alopecia areata and alopecia universalis to inhibit hair growth in transplants of human scalp skin grafted on to nude mice. Br J Dermatol 1992: 126: 166-171.
42. McElwee KJ, Hoffmann R, Freyschmidt-Paul P, et al,. Resistance to alopecia areata in C3H/HeJ mice is associated with increased expression of regulatory cytokines and a failure to recruit CD4+ and CD8+ cells. J Invest Dermatol 2002: 119: 1426-1433. (Pubitemid 36005631)
43. Perret C, Wiesner-Menzel L, Happle R,. Immunohistochemical analysis of T-cell subsets in the peribulbar and intrabulbar infiltrates of alopecia areata. Acta Derm Venereol 1984: 64: 26-30. (Pubitemid 14179563)
44. Ranki A, Kianto U, Kanerva L, Tolvanen E, Johansson E,. Immunohistochemical and electron microscopic characterization of the cellular infiltrate in alopecia (areata, totalis, and universalis). J Invest Dermatol 1984: 83: 7-11. (Pubitemid 14080891)
45. Bodemer C, Peuchmaur M, Fraitaig S, Chatenoud L, Brousse N, De Prost Y,. Role of cytotoxic T cells in chronic alopecia areata. J Invest Dermatol 2000: 114: 112-116. (Pubitemid 30195982)
46. Freyschmidt-Paul P, McElwee KJ, Botchkarev V, et al,. Fas-deficient C3.MRL-Tnfrsf6(lpr) mice and Fas ligand-deficient C3H/HeJ-Tnfsf6(gld) mice are relatively resistant to the induction of alopecia areata by grafting of alopecia areata-affected skin from C3H/HeJ mice. J Investig Dermatol Symp Proc 2003: 8: 104-108. (Pubitemid 36900500)
47. Zoller M, McElwee KJ, Engel P, Hoffmann R,. Transient CD44 variant isoform expression and reduction in CD4(+)/CD25(+) regulatory T cells in C3H/HeJ mice with alopecia areata. J Invest Dermatol 2002: 118: 983-992. (Pubitemid 34639176)
48. Zoller M, McElwee KJ, Vitacolonna M, Hoffmann R,. The progressive state, in contrast to the stable or regressive state of alopecia areata, is reflected in peripheral blood mononuclear cells. Exp Dermatol 2004: 13: 435-444. (Pubitemid 39077311)
49. Tobin DJ, Fenton DA, Kendall MD,. Cell degeneration in alopecia areata. An ultrastructural study. Am J Dermatopathol 1991: 13: 248-256.
50. Tobin DJ,. Morphological analysis of hair follicles in alopecia areata. Microsc Res Tech 1997: 38: 443-451. (Pubitemid 27377656)
51. Ito T, Meyer KC, Ito N, Paus R,. Immune privilege and the skin. Curr Dir Autoimmun 2008: 10: 27-52.
52. Paus R, Ito N, Takigawa M, Ito T,. The hair follicle and immune privilege. J Investig Dermatol Symp Proc 2003: 8: 188-194. (Pubitemid 37222828)
53. Paus R, Nickoloff BJ, Ito T,. A "hairy" privilege. Trends Immunol 2005: 26: 32-40.
54. Kalish RS, Gilhar A,. Alopecia areata: autoimmunity-the evidence is compelling. J Investig Dermatol Symp Proc 2003: 8: 164-167. (Pubitemid 37222823)
55. Ito T, Ito N, Bettermann A, Tokura Y, Takigawa M, Paus R,. Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model. Am J Pathol 2004: 164: 623-634. (Pubitemid 38364677)
56. Paus R, Christoph T, Muller-Rover S,. Immunology of the hair follicle: a short journey into terra incognita. J Investig Dermatol Symp Proc 1999: 4: 226-234. (Pubitemid 30085810)
57. Kang H, Wu WY, Lo BK, et al,. Hair follicles from alopecia areata patients exhibit alterations in immune privilege-associated gene expression in advance of hair loss. J Invest Dermatol 2010: 130: 2677-2680.
58. Ghersetich I, Campanile G, Lotti T,. Alopecia areata: immunohistochemistry and ultrastructure of infiltrate and identification of adhesion molecule receptors. Int J Dermatol 1996: 35: 28-33. (Pubitemid 26037042)
59. Gilhar A,. Collapse of immune privilege in alopecia areata: coincidental or substantial? J Invest Dermatol 2010: 130: 2535-2537.
60. Botchkareva NV, Ahluwalia G, Shander D,. Apoptosis in the hair follicle. J Invest Dermatol 2006: 126: 258-264. (Pubitemid 43323158)
61. Weedon D, Strutton G,. Apoptosis as the mechanism of the involution of hair follicles in catagen transformation. Acta Derm Venereol 1981: 61: 335-339. (Pubitemid 11034410)
62. Lindner G, Botchkarev VA, Botchkareva NV, Ling G, van der Veen C, Paus R,. Analysis of apoptosis during hair follicle regression (catagen). Am J Pathol 1997: 151: 1601-1617. (Pubitemid 27527923)
63. Eichmuller S, van der Veen C, Moll I, et al,. Clusters of perifollicular macrophages in normal murine skin: physiological degeneration of selected hair follicles by programmed organ deletion. J Histochem Cytochem 1998: 46: 361-370. (Pubitemid 28117386)
64. Parakkal PF,. Role of macrophages in collagen resorption during hair growth cycle. J Ultrastruct Res 1969: 29: 210-217.
65. McElwee K, Freyschmidt-Paul P, Ziegler A, Happle R, Hoffmann R,. Genetic susceptibility and severity of alopecia areata in human and animal models. Eur J Dermatol 2001: 11: 11-16. (Pubitemid 32153736)
66. Tobin DJ, Orentreich N, Fenton DA, Bystryn JC,. Antibodies to hair follicles in alopecia areata. J Invest Dermatol 1994: 102: 721-724. (Pubitemid 24144250)
67. McElwee KJ, Hoffmann R,. Alopecia areata-animal models. Clin Exp Dermatol 2002: 27: 410-417.
68. McElwee KJ, Freyschmidt-Paul P, Zoller M, Hoffmann R,. Alopecia areata susceptibility in rodent models. J Investig Dermatol Symp Proc 2003: 8: 182-187. (Pubitemid 37222827)
69. McElwee KJ, Yu M, Park SW, Ross EK, Finner A, Shapiro J,. What can we learn from animal models of alopecia areata? Dermatology 2005: 211: 47-53. (Pubitemid 40911564)
70. McElwee KJ, Silva K, Boggess D, Bechtold L, King LE Jr, Sundberg JP,. Alopecia areata in C3H/HeJ mice involves leukocyte-mediated root sheath disruption in advance of overt hair loss. Vet Pathol 2003: 40: 643-650. (Pubitemid 38393537)
71. Barahmani N, Schabath MB, Duvic M,. History of atopy or autoimmunity increases risk of alopecia areata. J Am Acad Dermatol 2009: 61: 581-591.
72. Lomas M, Hanon E, Tanaka Y, Bangham CR, Gould KG,. Presentation of a new H-2D(k)-restricted epitope in the Tax protein of human T-lymphotropic virus type I is enhanced by the proteasome inhibitor lactacystin. J Gen Virol 2002: 83: 641-650. (Pubitemid 34183009)
73. Ikeda T,. A new classification of alopecia areata. Dermatologica 1965: 131: 421-445.
74. Xiao FL, Yang S, Liu JB, et al,. The epidemiology of childhood alopecia areata in China: a study of 226 patients. Pediatr Dermatol 2006: 23: 13-18.
75. Nanda A, Al-Fouzan AS, Al-Hasawi F,. Alopecia areata in children: a clinical profile. Pediatr Dermatol 2002: 19: 482-485. (Pubitemid 35425144)
76. Goh C, Finkel M, Christos PJ, Sinha AA,. Profile of 513 patients with alopecia areata: associations of disease subtypes with atopy, autoimmune disease and positive family history. J Eur Acad Dermatol Venereol 2006: 20: 1055-1060. (Pubitemid 44425959)
77. Wang SJ, Shohat T, Vadheim C, Shellow W, Edwards J, Rotter JI,. Increased risk for type I (insulin-dependent) diabetes in relatives of patients with alopecia areata (AA). Am J Med Genet 1994: 51: 234-239. (Pubitemid 24184458)
78. Elenkov IJ, Chrousos GP,. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci 2002: 966: 290-303. (Pubitemid 34729188)
79. McElwee KJ, Silva K, Beamer WG, King LE Jr, Sundberg JP,. Melanocyte and gonad activity as potential severity modifying factors in C3H/HeJ mouse alopecia areata. Exp Dermatol 2001: 10: 420-429. (Pubitemid 33080993)
80. McElwee KJ, Niiyama S, Freyschmidt-Paul P, et al,. Dietary soy oil content and soy-derived phytoestrogen genistein increase resistance to alopecia areata onset in C3H/HeJ mice. Exp Dermatol 2003: 12: 30-36. (Pubitemid 36934687)
81. Rodriguez TA, Duvic M,. Onset of alopecia areata after Epstein-Barr virus infectious mononucleosis. J Am Acad Dermatol 2008: 59: 137-139.
82. Ikeda T,. Produced alopecia areata based on the focal infection theory and mental motive theory. Dermatologica 1967: 134: 1-11.
83. Brauner GJ, Goodheart HP,. Dermatologic care behind bars. J Am Acad Dermatol 1988: 18: 1066-1073.
84. Gupta MA, Gupta AK, Watteel GN,. Stress and alopecia areata: a psychodermatologic study. Acta Derm Venereol 1997: 77: 296-298. (Pubitemid 27286464)
85. Perini GI, Veller Fornasa C, Cipriani R, Bettin A, Zecchino F, Peserico A,. Life events and alopecia areata. Psychother Psychosom 1984: 41: 48-52. (Pubitemid 14169193)
86. Garcia-Hernandez MJ, Ruiz-Doblado S, Rodriguez-Pichardo A, Camacho F,. Alopecia areata, stress and psychiatric disorders: a review. J Dermatol 1999: 26: 625-632. (Pubitemid 29510343)
87. Chrousos GP,. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995: 332: 1351-1362.
88. Kakourou T, Karachristou K, Chrousos G,. A case series of alopecia areata in children: impact of personal and family history of stress and autoimmunity. J Eur Acad Dermatol Venereol 2007: 21: 356-359.
89. Brajac I, Tkalcic M, Dragojevic DM, Gruber F,. Roles of stress, stress perception and trait-anxiety in the onset and course of alopecia areata. J Dermatol 2003: 30: 871-878. (Pubitemid 38139976)
90. Picardi A, Pasquini P, Cattaruzza MS, et al,. Psychosomatic factors in first-onset alopecia areata. Psychosomatics 2003: 44: 374-381. (Pubitemid 37071924)
91. van der Steen P, Boezeman J, Duller P, Happle R,. Can alopecia areata be triggered by emotional stress? An uncontrolled evaluation of 178 patients with extensive hair loss. Acta Derm Venereol 1992: 72: 279-280.
92. Zhang X, Yu M, Yu W, Weinberg J, Shapiro J, McElwee KJ,. Development of alopecia areata is associated with higher central and peripheral hypothalamic-pituitary-adrenal tone in the skin graft induced C3H/HeJ mouse model. J Invest Dermatol 2009: 129: 1527-1538.
93. Katsarou-Katsari A, Singh LK, Theoharides TC,. Alopecia areata and affected skin CRH receptor upregulation induced by acute emotional stress. Dermatology 2001: 203: 157-161. (Pubitemid 34701577)
94. Isgor C, Cecchi M, Kabbaj M, Akil H, Watson SJ,. Estrogen receptor beta in the paraventricular nucleus of hypothalamus regulates the neuroendocrine response to stress and is regulated by corticosterone. Neuroscience 2003: 121: 837-845. (Pubitemid 37324582)
95. Ito N, Sugawara K, Bodo E, et al,. Corticotropin-releasing hormone stimulates the in situ generation of mast cells from precursors in the human hair follicle mesenchyme. J Invest Dermatol 2010: 130: 995-1004.
96. Ito T,. Hair follicle is a target of stress hormone and autoimmune reactions. J Dermatol Sci 2010: 60: 67-73.
97. Toyoda M, Makino T, Kagoura M, Morohashi M,. Expression of neuropeptide-degrading enzymes in alopecia areata: an immunohistochemical study. Br J Dermatol 2001: 144: 46-54. (Pubitemid 32154592)
98. Cetin ED, Savk E, Uslu M, Eskin M, Karul A,. Investigation of the inflammatory mechanisms in alopecia areata. Am J Dermatopathol 2009: 31: 53-60.
99. Siebenhaar F, Sharov AA, Peters EM, et al,. Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata). J Invest Dermatol 2007: 127: 1489-1497. (Pubitemid 46766534)
100. Trost LB, Bergfeld WF, Calogeras E,. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss. J Am Acad Dermatol 2006: 54: 824-844.
101. Boffa MJ, Wood P, Griffiths CE,. Iron status of patients with alopecia areata. Br J Dermatol 1995: 132: 662-664.
102. White MI, Currie J, Williams MP,. A study of the tissue iron status of patients with alopecia areata. Br J Dermatol 1994: 130: 261-263. (Pubitemid 24204632)
103. Gonul M, Cakmak SK, Soylu S, Kilic A, Gul U,. Serum vitamin B12, folate, ferritin, and iron levels in Turkish patients with alopecia areata. Indian J Dermatol Venereol Leprol 2009: 75: 552.
104. Wei H, Bowen R, Cai Q, Barnes S, Wang Y,. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med 1995: 208: 124-130.
105. Arnold HL Jr,. Alopecia areata; prevalence in Japanese and prognosis after reassurance. AMA Arch Derm Syphilol 1952: 66: 191-196.
106. Skinner RB Jr, Light WH, Bale GF, Rosenberg EW, Leonardi C,. Alopecia areata and presence of cytomegalovirus DNA. JAMA 1995: 273: 1419-1420.
107. Tosti A, La Placa M, Placucci F, et al,. No correlation between cytomegalovirus and alopecia areata. J Invest Dermatol 1996: 107: 443.
108. McElwee KJ, Boggess D, Burgett B, et al,. Murine cytomegalovirus is not associated with alopecia areata in C3H/HeJ mice. J Invest Dermatol 1998: 110: 986-987. (Pubitemid 28237710)
109. Offidani A, Amerio P, Bernardini ML, Feliciani C, Bossi G,. Role of cytomegalovirus replication in alopecia areata pathogenesis. J Cutan Med Surg 2000: 4: 63-65. (Pubitemid 30234935)
110. Garcia-Hernandez MJ, Torres MJ, Palomares JC, Rodriguez-Pichardo A, Aznar J, Camacho F,. No evidence of cytomegalovirus DNA in alopecia areata. J Invest Dermatol 1998: 110: 185. (Pubitemid 28105858)
111. Petukhova L, Duvic M, Hordinsky M, et al,. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature 2010: 466: 113-117.
112. Wise RP, Kiminyo KP, Salive ME,. Hair loss after routine immunizations. JAMA 1997: 278: 1176-1178. (Pubitemid 27422426)
113. Sundberg JP, Silva KA, Zhang W, et al,. Recombinant human hepatitis B vaccine initiating alopecia areata: testing the hypothesis using the C3H/HeJ mouse model. Vet Dermatol 2009: 20: 99-104.
114. McElwee KJ,. Etiology of cicatricial alopecias: a basic science point of view. Dermatol Ther 2008: 21: 212-220. (Pubitemid 352009066)
115. Otberg N, Wu WY, McElwee KJ, Shapiro J,. Diagnosis and management of primary cicatricial alopecia: part I. Skinmed 2008: 7: 19-26.
116. Wu WY, Otberg N, McElwee KJ, Shapiro J,. Diagnosis and management of primary cicatricial alopecia: part II. Skinmed 2008: 7: 78-83.
117. Sun J, Silva KA, McElwee KJ, King LE Jr, Sundberg JP,. The C3H/HeJ mouse and DEBR rat models for alopecia areata: review of preclinical drug screening approaches and results. Exp Dermatol 2008: 17: 793-805.
118. McBride AK, Bergfeld WF,. Mosaic hair color changes in alopecia areata. Cleve Clin J Med 1990: 57: 354-356. (Pubitemid 20320139)
119. Guin JD, Kumar V, Petersen BH,. Immunofluorescence findings in rapid whitening of scalp hair. Arch Dermatol 1981: 117: 576-578. (Pubitemid 11049433)
120. De Villez RL, Buchanan JM,. The graying phenomenon: an unusual manifestation of alopecia areata. Int J Dermatol 1982: 21: 344-346. (Pubitemid 12039895)
121. Gilhar A, Landau M, Assy B, Shalaginov R, Serafimovich S, Kalish RS,. Melanocyte-associated T cell epitopes can function as autoantigens for transfer of alopecia areata to human scalp explants on Prkdc(SCID) mice. J Invest Dermatol 2001: 117: 1357-1362. (Pubitemid 34032760)
122. Olsen EA, Hordinsky MK, Price VH, et al,. Alopecia areata investigational assessment guidelines-Part II. National Alopecia Areata Foundation. J Am Acad Dermatol 2004: 51: 440-447.
123. Ghoreishi M, Martinka M, Dutz JP,. Type 1 interferon signature in the scalp lesions of alopecia areata. Br J Dermatol 2010: 163: 57-62.
124. Freyschmidt-Paul P, McElwee KJ, Happle R, et al,. Interleukin-10- deficient mice are less susceptible to the induction of alopecia areata. J Invest Dermatol 2002: 119: 980-982. (Pubitemid 35340930)
125. Freyschmidt-Paul P, Zoller M, McElwee KJ, Sundberg J, Happle R, Hoffmann R,. The functional relevance of the type 1 cytokines IFN-gamma and IL-2 in alopecia areata of C3H/HeJ mice. J Investig Dermatol Symp Proc 2005: 10: 282-283.
126. Freyschmidt-Paul P, McElwee KJ, Hoffmann R, et al,. Reduced expression of interleukin-2 decreases the frequency of alopecia areata onset in C3H/HeJ mice. J Invest Dermatol 2005: 125: 945-951.
127. Freyschmidt-Paul P, McElwee KJ, Hoffmann R, et al,. Interferon-gamma- deficient mice are resistant to the development of alopecia areata. Br J Dermatol 2006: 155: 515-521. (Pubitemid 44215480)